Merxin

We are designers and suppliers of generic and customised inhaler device platforms. Our devices include multidose dry powder inhalers, capsule dry powder inhalers, soft mist inhalers, no heat no PG vaping devices and devices tailored to cannabinoid delivery to the lungs and nasal cavities. Our customers take our devices and combine them with their drug formulation to make final dosage forms that are supplied to users and patients. We create, develop and supply device platforms for evaluation through to commercial supply. Merxin device platforms save customers money and time to develop, file and market inhaled dosage forms. We take problems away from our customer. We do it so they don't have to. We are a trusted partner. We are part of the solution. Our DNA is in the pharma industry: we deliver quality, reliability and efficacy. The Merxin team has a thorough understanding and long history of medical device and pharmaceutical product development. Our reputation is built on excellence and audacity. Merxin is active in the fields of pharmaceuticals, inhaled cannabinoids therapies (iCTx) and reduced risk nicotine inhalers (RiNih). We make devices that treat lung diseases such as asthma, that make vaping safe and cannabis therapies reliable. Quality is in our veins. Merxin Ltd has been assessed and certified as meeting the requirements of ISO 13485: 2016 for the Design, Development and Supply of inhalers. We believe in Quality, we deliver Reliability. Established in the UK in 2015 and based in King's Lynn, with manufacturing capacity across the globe and an international client base, we are now adding more products to our portfolio and expanding rapidly, which is why we need you. In March we won the King's Lynn Mayor's Business of the Year Award.
Social Link - Twitter: https://twitter.com/mrxdevices
Social Link - Linkedin: http://www. linkedin.com/company /merxin-ltd
Employee Count: 8
Keywords: pharmaceuticals